Evaluation of a Structured Treatment and Teaching Program for Non-Insulin-Treated Type II Diabetic Outpatients in Germany After the Nationwide Introduction of Reimbursement Policy for Physicians

Monika Gruesser; Uwe Bott; Petra Ellermann; Petra Kronsbein; Viktor Joergens

doi:10.2337/diacare.16.9.1268

Original Articles

Evaluation of a Structured Treatment and Teaching Program for Non-Insulin-Treated Type II Diabetic Outpatients in Germany After the Nationwide Introduction of Reimbursement Policy for Physicians

Monika Gruesser, MD,
Uwe Bott, MS,
Petra Ellermann, MS,
Petra Kronsbein, DS and
Viktor Joergens, MD

Central Research Institute of Ambulatory Health Care Cologne, Germany Heinrich-Heine-University of Duesseldorf, Medical Department for Metabolic Diseases and Nutrition, World Health Organization Collaborating Center for Diabetes Cologne, Germany

Address correspondence and reprint requests to Monika Gruesser, MD, Zentralinstitut, Ottostrasse 1, D-5085g Koeln, Germany.

Diabetes Care 1993 Sep; 16(9): 1268-1275. https://doi.org/10.2337/diacare.16.9.1268

Abstract

Objective— To evaluate the practicability and efficacy of a structured treatment and teaching program for non-insulin-treated type II diabetic patients in routine primary health care.

Research Design and Methods— All physicians (n = 139) and their office staffs in Hamburg, Germany, who had participated in a special training course from 1 April 1991 to 31 December 1991 were contacted for a standardized interview. A random sample of 17 of these offices was selected for office visits during which the documented data of all patients who had received the standardized treatment and teaching in the same period were collected and evaluated.

Results— The program was well received by the physicians, and the data collected on 179 patients (5.1 mo median after the intervention) demonstrated the efficacy of the program at the treatment level: reduction of body weight (mean 2.8 kg, P < 0.0001) and HbA_1c levels (from 8.11 ± 1.68 to 7.47 ± 1.64%, P < 0.0001) was substantial. The individual prescribed volume of oral antidiabetic agents was ∼50% lower after patient attendance of the program (significant decrease from 1.41 ± 1.42 to 0.76 ± 1.11 tablets/patient/day, P < 0.0001). The proportion of patients treated with oral antidiabetic drugs decreased from 63 to 42% (P < 0.0001).

Conclusions— Subsequent to the introduction of nationwide remuneration of outpatient education for type II diabetic patients by office-based physicians, a relevant improvement was observed in the quality of care, comparable with the effects of the program in a previous prospective controlled trial.